Guidance

Medicines eligible for Northern Ireland MHRA Authorised Route

Sets out medicines that can be moved to Northern Ireland to meet patient need.

From:
Department of Health and Social Care
Published
16 December 2021
Last updated
34 September 2024 — See all updates

Documents

List of medicines that can be moved through NIMAR

CSV, 29.829.9 KB

View online

Details

This document lists the medicines eligible for supply through the Northern Ireland MHRA Authorised Route (NIMAR).

The listed medicines may be dispatched from Great Britain to Northern Ireland on the basis of the medicine’s authorisation in Great Britain.

This list is maintained and published in accordance with regulation 167B (list of NIMAR products) of the Human Medicines Regulations 2012 (SI 2012/1916, as amended).

Updates to this page

Published 16 December 2021
Last updated 34 September 2024 + show all updates

  1. Updated to add: Fabhalta 200mg capsules - Iptacopan Hydrocloride Monohydrate 200mg capsules.

  2. Updated to add and remove products. Added: Colobreathe 1,662,500 unit inhalation powder capsules - Colistimethate 1,662,500unit inhalation powder capsules; and Spikevax JN.1 0.1 mg/mL dispersion for injection mRNA-1273.167 - COVID-19 mRNA vaccine. Removed: Brivaracetam 75mg tablets.

  3. Updated to add and remove products. Added: Pegasys 90micrograms/0.5ml solution for injection pre-filled syringes - Peginterferon alfa-2a 90micrograms/0.5ml solution for injection pre-filled syringes; Remsima 100mg powder for concentrate for solution for infusion vials - Infliximab 100mg powder for concentrate for solution for infusion vials; Truxima 500mg/50ml concentrate for solution for infusion vials - Rituximab 500mg/50ml concentrate for solution for infusion vials. Removed: Cresemba 200mg powder for concentrate for solution for infusion vials - Isavuconazole 200mg powder for solution for infusion vials.

  4. Updated to add products to the list. Added: Eklira 322micrograms/dose Genuair - Aclidinium bromide 375micrograms/dose dry powder inhaler; and HyQvia 2.5g/25ml solution for infusion and 1.25ml vials - Normal immunoglobulin human 2.5g/25ml solution for infusion vials and Recombinant human hyaluronidase solution for infusion 1.25ml vials.

  5. Updated to add and remove products. Added: Truxima 100mg/10ml concentrate for solution for infusion vials - Rituximab 100mg/10ml solution for infusion vials; Yuflyma 40mg/0.4ml solution for injection pre-filled pens - Adalimumab 40mg/0.4ml solution for injection pre-filled disposable devices; Oseltamivir 30mg capsules; Oseltamivir 45mg capsules; Oseltamivir 75mg capsules; and Dacarbazine 1g powder for solution for infusion vials. Removed: Zonegran 25mg capsules - Zonisamide 25mg capsules.

  6. Added: Firdapse 10mg tablets - Amifampridine 10mg tablets.

  7. Added: perflutren-containing lipid microspheres 150 microlitres/ml gas and solvent for dispersion for injection/infusion.

  8. Updated to add products to the list: Pegasys 135micrograms/0.5ml solution for injection pre-filled syringes - Peginterferon alfa-2a 135micrograms/0.5ml solution for injection pre-filled syringes; and Pegasys 180micrograms/0.5ml solution for injection pre-filled syringes - Peginterferon alfa-2a 180micrograms/0.5ml solution for injection pre-filled syringes.

  9. Changed date in the ‘date added’ column from 12 July 2027 to 12 July 2024 for 2 products: Spexotras 50micrograms/ml oral solution - Trametinib 50micrograms/ml oral solution sugar free and Voxelotor 500mg tablets.

  10. Added to the list: Mounjaro KwikPen 15mg/0.6ml solution for injection 2.4ml pre-filled pens: Tirzepatide 15mg/0.6ml solution for injection 2.4ml pre-filled disposable devices, n/a: Voxelotor 500mg tablets, Finlee 10mg dispersible tablets: Dabrafenib 10mg dispersible tablets sugar free, Spexotras 50micrograms/ml oral solution: Trametinib 50micrograms/ml oral solution sugar free, Fluenz vaccine nasal suspension 0.2ml unit dose: Influenza vaccine (live attenuated) nasal suspension 0.2ml unit dose. Removed from the list: Fluenz Tetra vaccine nasal suspension 0.2ml unit dose: Influenza vaccine (live attenuated) nasal suspension 0.2ml unit dose.

  11. Removed from the list: Mylotarg 5mg powder for concentrate for solution for infusion vials: Gemtuzumab ozogamicin 5mg powder for solution for infusion vials, Nevirapine 50mg/5ml oral suspension, Talazoparib 1mg capsules, Talazoparib 250microgram capsules.

  12. Updated to add one product to the list: Takhyzro 150 mg solution for injection in pre-filled syringe - Lanadelumab 150 mg solution for injection in pre-filled syringe.

  13. Removed from the list: HyQvia 10g/100ml solution for infusion and 5ml vials: Normal immunoglobulin human 10g/100ml solution for infusion vials and Recombinant human hyaluronidase solution for infusion 5ml vials, Not applicable: Streptokinase 1.5million unit powder for solution for infusion vials, Not applicable: Streptokinase 250,000unit powder for solution for infusion vials.

  14. Updated to add and remove products. Added: Mounjaro KwikPen 7.5mg/0.6ml solution for injection 2.4ml pre-filled pens: Tirzepatide 7.5mg/0.6ml solution for injection 2.4ml pre-filled disposable devices; Mounjaro KwikPen 10mg/0.6ml solution for injection 2.4ml pre-filled pens: Tirzepatide 10mg/0.6ml solution for injection 2.4ml pre-filled disposable devices; Mounjaro KwikPen 12.5mg/0.6ml solution for injection 2.4ml pre-filled pens: Tirzepatide 12.5mg/0.6ml solution for injection 2.4ml pre-filled disposable devices. Removed: Briviact 10mg/ml oral solution: Brivaracetam 50mg/5ml oral solution sugar free; Oxaliplatin 200mg/40ml concentrate for solution for infusion vials.

  15. Removed from the list - Dupixent 300mg/2ml solution for injection pre-filled syringes: Dupilumab 300mg/2ml solution for injection pre-filled syringes; Lucentis 1.65mg/0.165ml solution for injection pre-filled syringes: Ranibizumab 1.65mg/0.165ml solution for injection pre-filled syringes; Nexpovio 20mg tablets: Selinexor 20mg tablets.

  16. Updated to add and remove products. Added: Brivaracetam 75mg tablets. Removed Dalbavancin (Xydalba) 500mg powder for concentrate for solution for infusion vial.

  17. Added to the list: Etrasimod 2mg tablets.

  18. Added to the list: Bosutinib 400mg tablets and Azathioprine 10mg/ml oral suspension sugar free.

  19. Added to the list: Nexpovio 20mg tablets: Selinexor 20mg tablets.

  20. Updated to add and remove products. Added: Briviact 10mg/ml oral solution: Brivaracetam 50mg/5ml oral solution sugar free; Cholestagel 625mg tablets: Colesevelam 625mg tablets; Cresemba 200mg powder vials: Isavuconazole 200mg powder for solution for infusion vials. Removed: Lurasidone 37mg tablets.

  21. Added 3 products to the list: Dupixent 300mg/2ml solution for injection pre-filled syringes: Dupilumab 300mg/2ml solution for injection pre-filled syringes; HyQvia 10g/100ml solution for infusion and 5ml vials: Normal immunoglobulin human 10g/100ml solution for infusion vials and Recombinant human hyaluronidase solution for infusion 5ml vials; and Trurapi 100 units/ml solution for injection in vial: insulin aspart 100 units/ml solution for injection in vial. Removed: Intuniv 4mg modified-release tablets: Guanfacine 4mg modified-release tablets.

  22. Added: Tamiflu 6mg/ml oral suspension - Oseltamivir 6mg/ml oral suspension sugar free.

  23. Added: Levomepromazine hydrochloride 25mg/5ml oral solution sugar free and Ritlecitinib 50mg capsules.

  24. Updated to add and remove products. Added: Amversio oral powder - Betaine oral powder; Vyvgart 1000mg/5.6ml solution for injection vials - Efgartigimod alfa 1g/5.6ml solution for injection vials; and Simbrinza 10mg/ml / 2mg/ml eye drops - Brinzolamide 10mg/ml / Brimonidine 2mg/ml eye drops. Removed: Oxaliplatin 50mg/10ml concentrate for solution for infusion vials.

  25. Added: Talazoparib 250microgram capsules; Talazoparib 1mg capsules; Intuniv 4mg modified-release tablets - Guanfacine 4mg modified-release tablets; Ferric maltol (iron 30mg) capsules; Nevirapine 50mg/5ml oral suspension; Kinpeygo 4mg modified-release capsules - Budesonide 4mg modified-release capsules; and Erivedge 150mg capsules - Vismodegib 150mg capsules. Removed: Insuman Comb 25 100units/ml suspension for injection 3ml cartridges - Insulin isophane biphasic human 25/75 100units/ml suspension for injection 3ml cartridges; Insuman Comb 25 100units/ml suspension for injection 3ml pre-filled SoloStar pens - Insulin isophane biphasic human 25/75 100units/ml suspension for injection 3ml pre-filled disposable devices; Insuman Basal 100units/ml suspension for injection 3ml cartridges - Insulin isophane human 100units/ml suspension for injection 3ml cartridges; and Sarilumab 150mg/1.14ml solution for injection pre-filled syringes.

  26. Added the following products to the list: Zonegran 25mg capsules: Zonisamide 25mg capsules; Zonegran 50mg capsules: Zonisamide 50mg capsules; Zonegran 100mg capsules: Zonisamide 100mg capsules; and n/a: Comirnaty Omicron XBB.1.5 COVID-19 mRNA Vaccine 30micrograms/0.3ml dose dispersion for injection single dose vials.

  27. Added: Atogepant 10mg tablets; Atogepant 60mg tablets; Mounjaro KwikPen 2.5mg/0.6ml solution for injection 2.4ml pre-filled pens - Tirzepatide 2.5mg/0.6ml solution for injection 2.4ml pre-filled disposable devices; and Mounjaro KwikPen 5mg/0.6ml solution for injection 2.4ml pre-filled pens - Tirzepatide 5mg/0.6ml solution for injection 2.4ml pre-filled disposable devices.

  28. Updated to add and remove products. Added: Panobinostat 10mg capsules. Removed: Xolair 150mg/1ml solution for injection pre-filled syringes - Omalizumab 150mg/1ml solution for injection pre-filled syringes; Remsima 100mg powder for concentrate for solution for infusion vials - Infliximab 100mg powder for solution for infusion vials; and Praluent 150mg/1ml solution for injection pre-filled pens - Alirocumab 150mg/1ml solution for injection pre-filled disposable devices.

  29. Added Xolair 150mg/1ml solution for injection pre-filled syringes: Omalizumab 150mg/1ml solution for injection pre-filled syringes.

  30. Updated to add Namuscla 167mg capsules - Mexiletine hydrochloride 200mg (Mexiletine 167mg) capsules; Nepafenac 1mg/ml eye drops; and Lurasidone 37mg tablets.

  31. Updated to add and remove products. Added: Ataluren 1g granules for oral suspension sachets; Ataluren 125mg granules for oral suspension sachets; and Ataluren 250mg granules for oral suspension sachets. Removed: Zonegran 100mg capsules - Zonisamide 100mg capsules; Zonegran 25mg capsules - Zonisamide 25mg capsules; Zonegran 50mg capsules - Zonisamide 50mg capsules; Praluent 75mg/1ml solution for injection pre-filled pens - Alirocumab 75mg/1ml solution for injection pre-filled disposable devices; Palbociclib 100mg tablets; Palbociclib 125mg tablets; Palbociclib 75mg tablets; and Voriconazole 200mg/5ml oral suspension.

  32. Updated to add Praluent 150mg/1ml solution for injection pre-filled pens - Alirocumab 150mg/1ml solution for injection pre-filled disposable devices; Lantus 100units/ml solution for injection 10ml vials - Insulin glargine 100units/ml solution for injection 10ml vials; and Remsima 100mg powder for concentrate for solution for infusion vials - Infliximab 100mg powder for solution for infusion vials.

  33. Updated to add and remove products. Added: Skyrizi 360mg/2.4ml solution for injection cartridges - Risankizumab 360mg/2.4ml solution for injection cartridges; and Bimzelx 160mg/1ml solution for injection pre-filled syringes - Bimekizumab 160mg/1ml solution for injection pre-filled syringes. Removed: Remicade 100mg powder for concentrate for solution for infusion vials - Infliximab 100mg powder for solution for infusion vials.

  34. Updated to add and remove products. Added: Mylotarg 5mg powder for concentrate for solution - Gemtuzumab ozogamicin 5mg powder for solution for infusion vials; and Kalydeco 13.4mg granules in sachet - Ivacaftor 13.4mg granules. Removed: Dupixent 300mg/2ml solution for injection pre-filled pens - Dupilumab 300mg/2ml solution for injection pre-filled disposable devices.

  35. Removed: Zerbaxa 1g/0.5g powder for concentrate for solution for infusion vials - Ceftolozane 1g / Tazobactam 500mg powder for solution for infusion vials; Ceftaroline fosamil 600mg powder for solution for infusion vials; and Vidaza 100mg powder for suspension for injection vials - Azacitidine 100mg powder for suspension for injection vials.

  36. Added: Myfenax 500mg tablets - Mycophenolate mofetil 500mg tablets; Belumosudil 200mg tablets; Tepkinly 48 mg/0.8ml solution for injection - Epcoritamab 48mg/0.8ml solution for injection vials; and Praluent 75mg/1ml solution for injection pre-filled pens - Alirocumab 75mg/1ml solution for injection pre-filled disposable devices. Removed: Cablivi 10mg powder and solvent for solution for injection - Caplacizumab 10mg powder and solvent for solution for injection; NovoMix 30 FlexPen 100units/ml suspension for injection 3ml pre-filled pens - Insulin aspart biphasic 30/70 100units/ml suspension for injection 3ml pre-filled disposable devices; NovoRapid PumpCart 100units/ml solution for injection 1.6ml cartridges - Insulin aspart 100units/ml solution for injection 1.6ml cartridges; Kalydeco 59.5 mg granules in sachet - Ivacaftor 59.5mg granules in sachet; Kaftrio 60 mg/40 mg/80 mg granules in sachet - Ivacaftor 60mg/Tezacaftor 40mg/Elexcaftor 80mg granules in sachet; Kalydeco 75 mg granules in sachet - Ivacaftor 75mg granules; Kaftrio 75 mg/50 mg/100 mg granules in sachet - Ivacaftor 75mg/Tezacaftor 50mg/Elexcaftor 100mg granules in sachet; and Gemcitabine 1.2g/120ml infusion bags.

  37. Updated to add and remove products. Added: Tepkinly 4 mg/0.8 ml concentrate for solution for injection - Epcoritamab 4mg/0.8ml concentrate for solution for injection vials. Removed: Spikevax XBB.1.5 COVID-19 mRNA Vaccine 0.1mg/1ml dispersion for injection multidose vials.

  38. Added: Bupivacaine liposomal 133mg/10ml prolonged-release dispersion for injection vials; Bupivacaine liposomal 266mg/20ml prolonged-release dispersion for injection vials; Vidaza 100mg powder for suspension for injection vials - Azacitidine 100mg powder for suspension for injection vials; Dupixent 300mg/2ml solution for injection pre-filled pens - Dupilumab 300mg/2ml solution for injection pre-filled disposable devices.

  39. Added: Filsuvez gel; Lomustine 40mg capsules.

  40. Updated to add and remove products. Added: Supemtek Quadrivalent vaccine (recombinant) solution for injection 0.5ml pre-filled syringes - Quadrivalent influenza vaccine (recombinant, inactivated) solution for injection 0.5ml pre-filled syringes; Nulojix 250mg powder for concentrate for solution for infusion vials - Belatacept 250mg powder for solution for infusion vials; Kaftrio 75 mg/50 mg/100 mg granules in sachet - Ivacaftor 75mg/Tezacaftor 50mg/Elexcaftor 100mg granules in sachet; Kaftrio 60 mg/40 mg/80 mg granules in sachet - Ivacaftor 60mg/Tezacaftor 40mg/Elexcaftor 80mg granules in sachet; Kalydeco 59.5 mg granules in sachet - Ivacaftor 59.5mg granules in sachet; and Kalydeco 75 mg granules in sachet - Ivacaftor 75mg granules. Removed: Adempas 1.5mg tablets - Riociguat 1.5mg tablets; Adempas 1mg tablets - Riociguat 1mg tablets; Adempas 2mg tablets - Riociguat 2mg tablets; Adempas 0.5mg tablets - Riociguat 500microgram tablets; Xolair 150mg/1ml solution for injection pre-filled syringes - Omalizumab 150mg/1ml solution for injection pre-filled syringes; and Linaclotide 290microgram capsules.

  41. Updated to add Cablivi 10mg powder and solvent for solution for injection - Caplacizumab 10mg powder and solvent for solution for injection.

  42. Updated to add NeoRecormon 6,000units/0.3ml solution for injection pre-filled syringes - Epoetin beta 6,000units/0.3ml solution for injection pre-filled syringes.

  43. Updated to add Zavicefta 2g/0.5g powder for concentrate for solution for infusion vials - Ceftazidime 2g/Avibactam 500mg powder for solution for infusion vials; and remove Acalabrutinib maleate 100mg film coated tablets.

  44. Added Acalabrutinib maleate 100mg film coated tablets.

  45. Added to the list: Ixiaro vaccine suspension for injection 0.5ml pre-filled syringes - Japanese encephalitis vaccine (inactivated, adsorbed) suspension for injection 0.5ml pre-filled syringes; Xermelo 250mg tablets - Telotristat 250mg tablets; Remicade 100mg powder for concentrate for solution for infusion vials - Infliximab 100mg powder for solution for infusion vials.

  46. Updated to add and remove items from the list. Added: Rotarix vaccine live oral suspension 1.5ml tube - rotavirus vaccine live oral suspension 1.5ml tube; and Ceftaroline fosamil 600mg powder for solution for infusion vials. Removed: Fluorouracil 2.5g/50ml solution for infusion vials; Ibandronic acid 2mg/2ml concentrate for solution for infusion vials; Ibandronic acid 6mg/6ml concentrate for solution for infusion vials; Orkambi 75 mg/94 mg granules in sachet - lumacaftor 75 mg/Ivacaftor 94 mg granules sachet; and Xermelo 250mg tablets - Telotristat 250mg tablets.

  47. Added: Xolair 150mg/1ml solution for injection pre-filled syringes - Omalizumab 150mg/1ml solution for injection pre-filled syringes; Fondaparinux sodium 2.5mg/0.5ml solution for injection pre-filled syringes; Fondaparinux sodium 5mg/0.4ml solution for injection pre-filled syringes; Fondaparinux sodium 7.5mg/0.6ml solution for injection pre-filled syringes; Fondaparinux sodium 10mg/0.8ml solution for injection pre-filled syringes.

  48. Added to the list: Ibandronic acid 2mg/2ml concentrate for solution for infusion vials and Ibandronic acid 6mg/6ml concentrate for solution for infusion vials.

  49. Added 'Salbutamol 2mg/1ml nebuliser liquid unit dose vials' to the list - it was accidently deleted in the previous update.

  50. Updated to add and remove items from the list. Added: Skyrizi 600mg/10ml concentrate for solution for infusion vials - Risankizumab 600mg/10ml solution for infusion vials. Removed: Gemcitabine 1.4g/140ml infusion bags; Gemcitabine 1.6g/160ml infusion bags; Gemcitabine 1.8g/180ml infusion bags; Gemcitabine 2.2g/220ml infusion bags; Gemcitabine 2g/200ml infusion bags; and Dupixent 300mg/2ml solution for injection pre-filled pens - Dupilumab 300mg/2ml solution for injection pre-filled disposable devices.

  51. Added to the list: Adempas 0.5mg tablets - Riociguat 500microgram tablets; Mayzent 2mg tablets - Siponimod 2mg tablets.

  52. Added to the list: Adempas 1.5mg tablets - Riociguat 1.5mg tablets; Adempas 1mg tablets - Riociguat 1mg tablets; Adempas 2mg tablets - Riociguat 2mg tablets; Mayzent 1mg tablets - Siponimod 1mg tablets; Mayzent 0.25mg tablets - Siponimod 250microgram tablets.

  53. Added: Evkeeza 150 mg/ml concentrate for solution for infusion - Evinacumab 150 mg/ml concentrate for solution for infusion vial; Voraxaze 1,000 unit powder for solution for injection vials - Glucarpidase 1,000 unit powder for solution for injection vials; and Linaclotide 290 microgram capsules.

  54. Added: Dupixent 300mg/2ml solution for injection pre-filled pens - Dupilumab 300mg/2ml solution for injection pre-filled disposable devices; and amended Telotristat 250mg tablets to add its brand name (Xermelo 250mg tablets).

  55. Added: Netupitant 300mg/Palonosetron hydrochloride 500micrograms capsules, Canakinumab 150mg/1ml solution for injection vials and Ofatumumab 20mg/0.4ml solution for injection pre-filled disposable devices.

  56. Added to the list: Rebif 22micrograms/0.5ml (6million units) solution for injection pre-filled pens - Interferon beta-1a 6million units/0.5ml solution for injection pre-filled disposable devices; Rebif 44micrograms/0.5ml (12million units) solution for injection pre-filled pens - Interferon beta-1a 12million units/0.5ml solution for injection pre-filled disposable devices; Bedaquiline 100mg tablets; Cometriq 20mg capsules - Cabozantinib 20mg capsules; Cometriq 80mg capsules - Cabozantinib 80mg capsules; Cometriq 20mg capsules and Cometriq 80mg capsules - Cabozantinib 20mg capsules and Cabozantinib 80mg capsules. Removed from the list: Doxorubicin 10mg/5ml solution for injection vials; Doxorubicin 50mg/25ml solution for injection vials; Methotrexate 1g/10ml solution for injection vials; Methotrexate 5g/50ml solution for infusion vials; Oxaliplatin 100mg/20ml concentrate for solution for infusion vials.

  57. Updated the list to add: Dalbavancin 500mg powder for solution for infusion vials; Dukoral cholera vaccine effervescent powder and suspension for oral suspension - cholera vaccine (inactivated, oral) effervescent powder and suspension for oral suspension; and Vaxchora vaccine effervescent powder and powder for oral suspension - cholera vaccine (recombinant, live, oral) effervescent powder and powder for oral suspension.

  58. Updated the list to add and remove the following products. Added: Trurapi 100units/ml solution for injection 3ml pre-filled Solostar pens - Insulin aspart 100units/ml solution for injection 3ml pre-filled disposable devices; Telotristat 250mg tablets; and Fidaxomicin 40mg/ml oral suspension sugar free. Removed: HyQvia 20g/200ml solution for infusion and 10ml vials - Normal immunoglobulin human 20g/200ml solution for infusion vials; and Recombinant human hyaluronidase solution for infusion 10ml vials.

  59. Added 'NovoRapid FlexTouch 100units/ml solution for injection 3ml pre-filled pens' to the list - it was accidently deleted in the previous update.

  60. Added: Acetylcysteine 200mg oral powder sachets sugar free and Epirubicin 200mg/100ml solution for infusion vials. Removed: Insulin aspart 100units/ml solution for injection 3ml pre-filled disposable devices and Remdesivir 100mg powder for solution for infusion vials

  61. Added: Nivestim 12million units/0.2ml solution for injection pre-filled syringes - Filgrastim 12million units/0.2ml solution for injection pre-filled syringes; Kiovig 2.5g/25ml solution for infusion vials - Normal immunoglobulin human 2.5g/25ml solution for infusion vials; Zonegran 100mg capsules - Zonisamide 100mg capsules; Zonegran 25mg capsules - Zonisamide 25mg capsules; and Zonegran 50mg capsules - Zonisamide 50mg capsules. Removed: Xultophy 100units/ml / 3.6mg/ml solution for injection 3ml pre-filled pens - Insulin degludec 100units/ml / Liraglutide 3.6mg/ml solution for injection 3ml pre-filled disposable devices; and Kiovig 10g/100ml solution for infusion vials - Normal immunoglobulin human 10g/100ml solution for infusion vials.

  62. Added to the list: Spikevax XBB.1.5 COVID-19 mRNA Vaccine 0.1mg/1ml dispersion for injection multidose vials.

  63. Added Nelarabine 5mg/ml solution for infusion to the list.

  64. Added: Fluorouracil 5g/100ml solution for infusion vials and Fluorouracil 2.5g/50ml solution for infusion vials. Removed: NovoRapid FlexPen 100units/ml solution for injection 3ml pre-filled pens.

  65. Added to the list: Leflunomide 10mg tablets; Ranibizumab 1.65mg/0.165ml solution for injection pre-filled syringes; Dacarbazine 500mg powder for solution for infusion vials.

  66. Added the following products to the list: Semaglutide 0.25 in 0.37ml solution for injection in a prefilled device; Semaglutide 0.5mg in 0.37ml solution for injection in a prefilled device; Semaglutide 1mg in 0.75ml solution for injection in a prefilled device; Semaglutide 1.7mg in 0.75ml solution for injection in a prefilled device; Semaglutide 2.4mg in 0.75ml solution for injection in a prefilled device; and Novomix 30 FlexPen 100units/ml solution for injection 3ml pre-filled pens (Insulin aspart biphasic 30/70 100units/ml suspension for injection 3ml pre-filled disposable devices).

  67. Added: Panobinostat 15mg capsules; Panobinostat 20mg capsules; Physeptone 1mg/ml oral solution sugar free - Methadone 1mg/ml oral solution sugar free. Removed: Clopidogrel 300mg tablets.

  68. Added: HyQvia 20g/200ml solution for infusion and 10ml vials - Normal immunoglobulin human 20g/200ml solution for infusion vials and Recombinant human hyaluronidase solution for infusion 10ml vials and; Xultophy 100units/ml / 3.6mg/ml solution for injection 3ml pre-filled pens - Insulin degludec 100units/ml / Liraglutide 3.6mg/ml solution for injection 3ml pre-filled disposable devices.

  69. Added to the list: Aprepitant 125mg oral powder sachets; Acetylcholine chloride 20mg powder and solvent for solution for intraocular irrigation ampoules; Omalizumab 75mg/0.5ml solution for injection pre-filled syringes; Doxorubicin 50mg/25ml solution for injection vials; Doxorubicin 10mg/5ml solution for injection vials. Removed from the list: Fondaparinux sodium 5mg/0.4ml solution for injection pre-filled syringes; Toujeo 300units/ml solution for injection 3ml pre-filled DoubleStar pens - Insulin glargine 300units/ml solution for injection 3ml pre-filled disposable devices; Kiovig 20g/200ml solution for infusion vials - Normal immunoglobulin human 20g/200ml solution for infusion vials; Kiovig 5g/50ml solution for infusion vials - Normal immunoglobulin human 5g/50ml solution for infusion vials; Adempas 2.5mg tablets - Riociguat 2.5mg tablets; Senna fruit 12.4% / Ispaghula 54.2% granules; Omalizumab 150mg/1ml solution for injection pre-filled syringes.

  70. Added to the list: (Zerbaxa 1g/0.5g powder for concentrate for solution for infusion vials) Ceftolozane 1g / Tazobactam 500mg powder for solution for infusion vials.

  71. Added to the list: Oxaliplatin 100mg/20ml concentrate for solution for infusion vials; Oxaliplatin 200mg/40ml concentrate for solution for infusion vials; Oxaliplatin 50mg/10ml concentrate for solution for infusion vials.

  72. The following product was added to the list: Voriconazole 200mg/5ml oral suspension. Removed from the list: Canagliflozin 300mg tablets.

  73. The following products have been removed from the list: Ertugliflozin 5mg tablets; (Fiasp FlexTouch 100units/ml solution for injection 3ml pre-filled pens) Insulin aspart 100units/ml solution for injection 3ml pre-filled disposable devices; Sarclisa 500mg/25ml concentrate for solution for infusion vials (Isatuximab 500mg/25ml solution for infusion vials); Omalizumab 75mg/0.5ml solution for injection pre-filled syringes; (Keytruda 100mg/4ml concentrate for solution for infusion vials) Pembrolizumab 100mg/4ml solution for infusion vials; Sitagliptin 25mg tablets; Sitagliptin 50mg tablets; Sugammadex 200mg/2ml solution for injection vials; and Sugammadex 500mg/5ml solution for injection vials.

  74. Added to the list: (Venclyxto 100mg tablets) Venetoclax 100mg tablets; (Venclyxto 10mg tablets) Venetoclax 10mg tablets; and (Venclyxto 50mg tablets) Venetoclax 50mg tablets.

  75. Added: (Adempas 2.5mg tablets) Riociguat 2.5mg tablets; Fondaparinux sodium 5mg/0.4ml solution for injection pre-filled syringes and; Fosaprepitant 150mg powder for solution for infusion vials.

  76. Added to the list: Sarclisa 500mg/25ml concentrate for solution for infusion vials - Isatuximab 500mg/25ml solution for infusion vials

  77. Added to the list: (Toujeo 300units/ml solution for injection 3ml pre-filled DoubleStar pens) Insulin glargine 300units/ml solution for injection 3ml pre-filled disposable devices; (Fiasp FlexTouch 100units/ml solution for injection 3ml pre-filled pens) Insulin aspart 100units/ml solution for injection 3ml pre-filled disposable devices; (Avamys 27.5micrograms/dose nasal spray) Fluticasone furoate 27.5micrograms/dose nasal spray; Tedizolid 200mg tablets. Removed from the list: (Palexia SR 100mg tablets) Tapentadol 100mg modified-release tablets; (Palexia SR 150mg tablets) Tapentadol 150mg modified-release tablets; (Palexia SR 200mg tablets) Tapentadol 200mg modified-release tablets; (Palexia SR 50mg tablets) Tapentadol 50mg modified-release tablets; (Palexia 50mg tablets) Tapentadol 50mg tablets; (Palexia 75mg tablets) Tapentadol 75mg tablets.

  78. The following products have been added to the list: Gemcitabine 1.2g/120ml infusion bags; Gemcitabine 1.4g/140ml infusion bags; Gemcitabine 1.6g/160ml infusion bags; Gemcitabine 1.8g/180ml infusion bags; Gemcitabine 2.2g/220ml infusion bags; Gemcitabine 2g/200ml infusion bags; and Semaglutide 1mg/0.74ml solution for injection 3ml pre-filled disposable device.

  79. (Palexia SR 100mg tablets) Tapentadol 100mg modified-release tablets; (Palexia SR 150mg tablets) Tapentadol 150mg modified-release tablets; (Palexia SR 200mg tablets) Tapentadol 200mg modified-release tablets; (Palexia SR 50mg tablets) Tapentadol 50mg modified-release tablets; (Palexia 50mg tablets) Tapentadol 50mg tablets; (Palexia 75mg tablets) Tapentadol 75mg tablets

  80. Added to the list: Glecaprevir 100mg / Pibrentasvir 40mg tablets.

  81. The following products have been added to the list: (Epistatus 2.5mg/0.25ml oromucosal solution pre-filled oral syringes) Midazolam 2.5mg/0.25ml oromucosal solution pre-filled oral syringes sugar free; (Epistatus 5mg/0.5ml oromucosal solution pre-filled oral syringes) Midazolam 5mg/0.5ml oromucosal solution pre-filled oral syringes sugar free; and (Epistatus 7.5mg/0.75ml oromucosal solution pre-filled oral syringes) Midazolam 7.5mg/0.75ml oromucosal solution pre-filled oral syringes sugar free. The following product has been changed: Exenatide 2mg injection to Exenatide 2mg/0.85ml prolonged-release suspension for injection pre-filled disposable devices.

  82. Added to the list: Isentress 100mg granules sachets - Raltegravir 100mg granules sachets; KEYTRUDA 25mg/mL concentrate for solution for infusion; Zepatier 50mg/100mg tablets - Elbasvir 50mg/Grazoprevir 100mg tablets.

  83. Added to the list: Canagliflozin 300mg tablets; Ertugliflozin 5mg tablets; (NovoRapid FlexPen 100units/ml solution for injection 3ml pre-filled pens) Insulin aspart 100units/ml solution for injection 3ml pre-filled disposable devices; Sitagliptin 25mg tablets; Sitagliptin 50mg tablets; Sugammadex 200mg/2ml solution for injection vials; Sugammadex 500mg/5ml solution for injection vials.

  84. Added: Pyridostigmine bromide 12mg/1ml oral solution sugar free.

  85. Added: Semaglutide 3mg tablets; Semaglutide 7mg tablets; Semaglutide 14mg tablets; Insulin aspart 100units/ml solution for injection 1.6ml cartridges (NovoRapid PumpCart 100units/ml solution for injection 1.6ml cartridges); Glucagon 500micrograms/0.1ml solution for injection pre-filled disposable devices; Hydroxychloroquine 300mg tablets; Hepatitis A (inactivated) / Hepatitis B (rDNA) vaccine (adsorbed) suspension for injection 0.5ml pre-filled syringes (Twinrix Paediatric vaccine suspension for injection 0.5ml pre-filled syringes); Hepatitis A (inactivated) / Hepatitis B (rDNA) vaccine (adsorbed) suspension for injection 1ml pre-filled syringes (Twinrix Adult vaccine suspension for injection 1ml pre-filled syringes). Removed: Toujeo 300units/ml solution for injection 3ml pre-filled DoubleStar pens; Pelmeg 6mg/0.6ml solution for injection pre-filled syringes; Ertapenem 1g powder for solution for infusion vials. Amended: Tiaprofenic acid 200mg tablets should be tiaprofenic acid 300mg tablets

  86. Added 2 medicines to the list: Senna fruit 12.4% / Ispaghula 54.2% granules; and Midazolam 10mg/1ml oromucosal solution pre-filled oral syringes sugar free (Epistatus 10mg/1ml oromucosal solution pre-filled oral syringes).

  87. The following products have been added to the list: Ertapenem 1g powder for solution for infusion vials.

  88. The following products have been added to the list: (Praluent 300mg/2ml solution for injection pre-filled pens) Alirocumab 300mg/2ml solution for injection pre-filled disposable devices, Estradiol valerate 1mg / Medroxyprogesterone 5mg tablets, (Kiovig 10g/100ml solution for infusion vials) Normal immunoglobulin human 10g/100ml solution for infusion vials, (Kiovig 20g/200ml solution for infusion vials) Normal immunoglobulin human 20g/200ml solution for infusion vials, (Kiovig 5g/50ml solution for infusion vials) Normal immunoglobulin human 5g/50ml solution for infusion vials, and Tiaprofenic acid 200mg tablets. The following products have been removed from the list: Canagliflozin 100mg tablets, Canagliflozin 300mg tablets, and Secukinumab 150mg/1ml solution for injection pre-filled disposable devices.

  89. Added: (Pelmeg 6mg/0.6ml solution for injection pre-filled syringes) Pegfilgrastim 6mg/0.6ml solution for injection pre-filled syringes. Removed: (Benlysta 200mg/1ml solution for injection pre-filled pens) Belimumab 200mg/1ml solution for injection pre-filled disposable devices. Changed: Imatinib 100mg tablets to (Glivec 100 mg tablets) Imatinib 100mg tablets and Imatinib 400mg tablets to (Glivec 400 mg tablets) Imatinib 400mg tablets.

  90. The following products have been added to the list: (Benlysta 200mg/1ml solution for injection pre-filled pens) Belimumab 200mg/1ml solution for injection pre-filled disposable devices, (Toujeo 300units/ml solution for injection 3ml pre-filled DoubleStar pens) Insulin glargine 300units/ml solution for injection 3ml pre-filled disposable devices, and (Orkambi 75 mg/94 mg granules in sachet) Lumacaftor 75 mg/Ivacaftor 94 mg granules sachet. The following product has been removed from the list: (Remsima 100mg powder for concentrate for solution for infusion vials) Infliximab 100mg powder for solution for infusion vials.

  91. The following products have been added to the list: Buprenorphine 128mg/0.36ml prolonged-release solution for injection pre-filled syringes; Buprenorphine 160mg/0.45ml prolonged-release solution for injection pre-filled syringes; Buprenorphine 16mg/0.32ml prolonged-release solution for injection pre-filled syringes; Buprenorphine 24mg/0.48ml prolonged-release solution for injection pre-filled syringes; Buprenorphine 32mg/0.64ml prolonged-release solution for injection pre-filled syringes; Buprenorphine 64mg/0.18ml prolonged-release solution for injection pre-filled syringes; Buprenorphine 8mg/0.16ml prolonged-release solution for injection pre-filled syringes; Buprenorphine 96mg/0.27ml prolonged-release solution for injection pre-filled syringes

  92. Added: (Remsima 120mg/1ml solution for injection pre-filled pens) Infliximab 120mg/1ml solution for injection pre-filled disposable devices.

  93. Added: (Byetta 10micrograms/0.04ml solution for injection 2.4ml pre-filled pens) Exenatide 10micrograms/0.04ml solution for injection 2.4ml pre-filled disposable devices; (Byetta 5micrograms/0.02ml solution for injection 1.2ml pre-filled pens) Exenatide 5micrograms/0.02ml solution for injection 1.2ml pre-filled disposable devices; Hydroxycarbamide 100mg tablets.

  94. Added: Avalglucosidase alfa 100mg powder for solution for infusion vials; Etoposide 100mg/5ml solution for infusion vials. Removed: (Truxima 500mg/50ml concentrate for solution for infusion vials) Rituximab 500mg/50ml solution for infusion vials.

  95. Added: Canagliflozin 100mg tablets and Canagliflozin 300mg tablets. Removed (Toujeo 300units/ml solution for injection 3ml pre-filled DoubleStar pens) Insulin glargine 300units/ml solution for injection 3ml pre-filled disposable devices; Upadacitinib 45mg modified-release tablets; and (Plavix 75mg tablets) Clopidogrel 75mg tablets.

  96. Updated to add (Plavix 75mg tablets) Clopidogrel 75mg tablets.

  97. Removed from the list: Patisiran 2 mg/ml concentrate for solution for infusion. Added to the list: Methotrexate 1g/10ml solution for injection vials and Methotrexate 5g/50ml solution for infusion vials.

  98. Updated to add 'Nuvaxovid COVID-19 Vaccine (recombinant, adjuvanted) dispersion for injection' and to remove 'Cell-based quadrivalent influenza vaccine (surface antigen, inactivated) suspension for injection 0.5ml pre-filled syringes'.

  99. The following medicine has been added to the list: (Toujeo 300units/ml solution for injection 3ml pre-filled DoubleStar pens) Insulin glargine 300units/ml solution for injection 3ml pre-filled disposable devices, and the following 6 medicines have been removed from the list: (HyQvia 10g/100ml solution for infusion and 5ml vials) Normal immunoglobulin human 10g/100ml solution for infusion vials and Recombinant human hyaluronidase solution for infusion 5ml vials, (HyQvia 2.5g/25ml solution for infusion and 1.25ml vials) Normal immunoglobulin human 2.5g/25ml solution for infusion vials and Recombinant human hyaluronidase solution for infusion 1.25ml vials, (HyQvia 30g/300ml solution for infusion and 15ml vials) Normal immunoglobulin human 30g/300ml solution for infusion vials and Recombinant human hyaluronidase solution for infusion 15ml vials, (HyQvia 5g/50ml solution for infusion and 2.5ml vials) Normal immunoglobulin human 5g/50ml solution for infusion vials and Recombinant human hyaluronidase solution for infusion 2.5ml vials, (Fotivda 1340microgram capsules) Tivozanib 1340microgram capsules, and (Fotivda 890microgram capsules) Tivozanib 890microgram capsules.

  100. Changed '(Esperoct 5000 unit powder and solvent for solution for injection vials) Turoctocog alfa pegol 500 unit powder and solvent for solution for injection vials' to: '(Esperoct 500 unit powder and solvent for solution for injection vials) Turoctocog alfa pegol 500 unit powder and solvent for solution for injection vials'. Added the following medicines to the list: Ibandronic acid 50mg tablets; Lixisenatide 20mg / 0.2ml solution for injection 3ml pre-filled disposable devices; Potassium citrate 282mg / Potassium bicarbonate 527mg modified-release granules sachets sugar free; and Potassium citrate 847mg / Potassium bicarbonate 1.582g modified-release granules sachets sugar free.

  101. 28 products have been added to the list: Normal immunoglobulin human 2.5g/25ml solution for infusion vials and Recombinant human hyaluronidase solution for infusion 1.25ml vials; Normal immunoglobulin human 5g/50ml solution for infusion vials and Recombinant human hyaluronidase solution for infusion 2.5ml vials; Normal immunoglobulin human 10g/100ml solution for infusion vials and Recombinant human hyaluronidase solution for infusion 5ml vials; Normal immunoglobulin human 30g/300ml solution for infusion vials and Recombinant human hyaluronidase solution for infusion 15ml vials; Naloxone 1.8mg/0.1ml nasal spray unit dose; Glycopyrronium 7.2micrograms/dose / Formoterol 5micrograms/dose inhaler CFC free; Interferon beta-1b 300microgram powder and solvent for solution for injection vials; Saxagliptin 2.5mg / Metformin 1g tablets; Saxagliptin 5mg / Dapagliflozin 10mg tablets; Eptacog alfa (activated) 1mg (50,000unit) powder and solvent for solution for injection pre-filled syringes; Eptacog alfa (activated) 2mg (100,000unit) powder and solvent for solution for injection pre-filled syringes; Eptacog alfa (activated) 5mg (250,000unit) powder and solvent for solution for injection pre-filled syringes; Eptacog alfa (activated) 8mg (400,000unit) powder and solvent for solution for injection pre-filled syringes; Turoctocog alfa pegol 1,000unit powder and solvent for solution for injection vials; Turoctocog alfa pegol 1,500unit powder and solvent for solution for injection vials; Turoctocog alfa pegol 2,000unit powder and solvent for solution for injection vials; Turoctocog alfa pegol 3,000unit powder and solvent for solution for injection vials; Turoctocog alfa pegol 500unit powder and solvent for solution for injection vials; Turoctocog alfa 250unit powder and solvent for solution for injection vials; Turoctocog alfa 500unit powder and solvent for solution for injection vials; Turoctocog alfa 1,000unit powder and solvent for solution for injection vials; Turoctocog alfa 1,500unit powder and solvent for solution for injection vials; Turoctocog alfa 2,000unit powder and solvent for solution for injection vials; Turoctocog alfa 3,000unit powder and solvent for solution for injection vials; Catridecacog 2,500unit powder and solvent for solution for injection vials; Nonacog beta pegol 1,000unit powder and solvent for solution for injection vials; Nonacog beta pegol 2,000unit powder and solvent for solution for injection vials; Nonacog beta pegol 500unit powder and solvent for solution for injection vials

  102. Added 2 products to the list: Omalizumab 75mg/0.5ml solution for injection pre-filled syringes and Oxybutynin 3.9mg/24 hours transdermal patches.

  103. Added: (NovoRapid FlexTouch 100units/ml solution for injection 3ml pre-filled pens) Insulin aspart 100units/ml solution for injection 3ml pre-filled disposable devices; Erenumab 140mg/1ml solution for injection pre-filled disposable devices; Erenumab 70mg/1ml solution for injection pre-filled disposable devices; Sarilumab 150mg/1.14ml solution for injection pre-filled syringes; Sarilumab 200mg/1.14ml solution for injection pre-filled syringes; Sarilumab 150mg/1.14ml solution for injection pre-filled disposable devices; Sarilumab 200mg/1.14ml solution for injection pre-filled disposable devices; Mitomycin 40mg powder and solvent for intravesical solution vials; Imatinib 100mg tablets; Imatinib 400mg tablets. Removed: Bimatoprost 300micrograms/ml eye drops 0.4ml unit dose preservative free. Changed: Simulect 10mg powder and solvent forsolution for injection vials (1 vial) to Basiliximab 10mg powder and solvent forsolution for injection vials; Simulect 20mg powder and solvent for solution for injection vials to Basiliximab 20mg powder and solvent for solution for injection vials.

  104. Added: Conestat alfa 2,100 unit powder and solvent for solution for injection vials.

  105. Added: Mobocertinib 40mg capsules, Truxima (Rituximab) 500mg/50ml concentrate for solution for infusion vials, Votubia (Everolimus) 10mg tablets, Votubia (Everolimus) 2.5mg tablets, Votubia (Everolimus) 5mg tablets, Everolimus 2mg dispersible tablets, and Everolimus 5mg dispersible tablets. Removed: Benralizumab 30mg/1ml solution for injection pre-filled disposable devices.

  106. Added the following 4 medicines: Salbutamol 5mg/2.5ml nebuliser liquid unit dose vials, Salbutamol 1mg/1ml nebuliser liquid unit dose vials, Salbutamol 2mg/1ml nebuliser liquid unit dose vials, Tivozanib 1340mg capsules and Tivozanib 890mg capsules. Removed the following medicine: Bexarotene 75mg capsules.

  107. Added the following medicine to the list: Salbutamol 2.5mg/2.5ml nebuliser liquid unit dose vials. Removed the following medicine from the list: Amlodipine/Valsartan 10mg/160mg tablets; Amlodipine/Valsartan 5mg/80mg tablets.

  108. The following medicines have been added to the list: Alpelisib 50mg tablets, Alpelisib 200mg tablets, Alpelisib 150mg tablets, Alpelisib 50mg tablets and Alpelisib 200mg tablets, Darifenacin 7.5mg modified-release tablets, Darifenacin 15mg modified-release tablets, Rucaparib 200mg tablets, Rucaparib 250mg tablets, Rucaparib 300mg tablets, Benralizumab 30mg/1ml solution for injection pre-filled disposable devices.

  109. Added the following medicines to the list: (Trurapi 100 units/ml solution for injection 3ml pre-filled Solostar pens) Insulin aspart 100 units/ml solution for injection 3ml pre-filled disposable devices and Remdesivir 100mg powder for solution for infusion vials. Removed (Truxima 500mg/50ml concentrate for solution for infusion vials) Rituximab 500mg/50ml solution for infusion vials.

  110. Added the following medicine to the list: Reslizumab 100mg/10ml solution for infusion vials; Clopidogrel 300mg tablets; Eltrombopag 75mg tablets; (Remsima 100mg powder for concentrate for solution for infusion vials) Infliximab 100mg powder for solution for infusion vials. Removed the following medicine from the list: Glycopyrronium 44microgram inhalation powder capsules with device; Perampanel 10mg tablets; Perampanel 12mg tablets; Perampanel 2mg tablets; Perampanel 4mg tablets; Perampanel 500micrograms/ml oral suspension sugar free; Perampanel 6mg tablets; Perampanel 8mg tablets; Regadenoson 400micrograms/5ml solution for injection vials. Changed medicines (updated descriptions): Amlodipine/Valsartan 10mg/160mg to Amlodipine/Valsartan 10mg/160mg tablets; Amlodipine/Valsartan 5mg/160mg to Amlodipine/Valsartan 5mg/160mg tablets; Amlodipine/Valsartan 5mg/80mg to Amlodipine/Valsartan 5mg/80mg tablets; Choriogonadotropin to Choriogonadotropin 250micrograms/0.5ml solution for injection pre-filled syringes.

  111. Added the following medicine to the list: Perampanel 500micrograms/ml oral suspension sugar free.

  112. Added the following 16 medicines to the list: Perampanel 2mg tablets; Perampanel 4mg tablets; Perampanel 6mg tablets; Perampanel 8 mg tablets; Perampanel 10mg tablets; Perampanel 12mg tablets; Sodium tetradecyl sulfate 3% solution for injection vials; Sodium tetradecyl sulfate 3% solution for injection ampoules; Sodium tetradecyl sulfate 1% solution for injection ampoules; Sodium tetradecyl sulfate 0.5% solution for injection ampoules; Sodium tetradecyl sulfate 0.2% solution for injection vials; Ovitrelle 250mg/0.5ml solution for injection pre-filled syringes; Choriogonadotropin alfa 250mg/0.5ml solution for injection pre-filled syringes; Dornase alfa 2.5mg nebuliser liquid 2.5ml ampoules; Exenatide 2mg injection; Saxagliptin 2.5mg tablets; and Saxagliptin 5mg tablets. Removed the following 2 medicines from the list: Hemlibra 30mg/1ml solution for injection vials; Emicizumab 30mg/1ml solution for injection vials; and Epirubicin 200mg/100ml solution for infusion vials.

  113. Updated the list to correct a dosage error: changed Secukinumab 300mg/2ml solution for injection pre-filled disposable devices to Secukinumab 150mg/1ml solution for injection pre-filled disposable devices.

  114. Added the following medicines to the list: Bimatoprost 300micrograms/ml eye drops 0.4ml unit dose preservative free; (Truxima 500mg/50ml concentrate for solution for infusion vials) Rituximab 500mg/50ml solution for infusion vials; and Secukinumab 300mg/2ml solution for injection pre-filled disposable devices. Changed Basiliximab 10mg powder and solvent for solution for injection vials (1 vial) to Simulect 10mg powder and solvent for solution for injection vials (1 vial) (brand to generic).

  115. Removed the ‘NutropinAq 10mg/2ml solution for injection cartridges’ brand name from the following generic medicines: Regadenoson 400micrograms/5ml solution for injection vials; Omalizumab 150mg/1ml solution for injection pre-filled syringes; Fondaparinux sodium 1.5mg/0.3ml solution for injection pre-filled syringes; Simulect 20mg powder and solvent for solution for injection vials; Enfuvirtide 108mg powder and solvent for solution for injection vials; Upadacitinib 45mg modified-release tablets.

  116. Added the following medicines: NutropinAq 10mg/2ml solution for injection cartridges (Enfuvirtide 108mg powder and solvent for solution for injection vials); NutropinAq 10mg/2ml solution for injection cartridges (Fondaparinux sodium 1.5mg/0.3ml solution for injection pre-filled syringes); NutropinAq 10mg/2ml solution for injection cartridges (Omalizumab 150mg/1ml solution for injection pre-filled syringes); NutropinAq 10mg/2ml solution for injection cartridges (Regadenoson 400micrograms/5ml solution for injection vials); NutropinAq 10mg/2ml solution for injection cartridges (Simulect 20mg powder and solvent for solution for injection vials); NutropinAq 10mg/2ml solution for injection cartridges (Somatropin (rbe) 10mg/2ml solution for injection cartridges); NutropinAq 10mg/2ml solution for injection cartridges (Upadacitinib 45mg modified-release tablets). Removed the following medicines: Fondaparinux sodium 10mg/0.8 ml solution for injection, pre-filled syringe; Fondaparinux sodium 7mg/0.6 ml solution for injection, pre-filled syringe; Fondaparinux sodium 5mg/0.4 ml solution for injection, pre-filled syringe.

  117. Updated the list of medicines that can be moved through NIMAR, adding the following: Basiliximab 10mg powder and solvent for solution for injection vials (1 vial), Suboxone 2mg/500microgram sublingual tablets, Suboxone 8mg/2mg sublingual tablets, Hemlibra 30mg/1ml solution for injection vials, Glycopyrronium 44 microgram inhalation powder capsules with device, Levemir Innolet 100 units/ml solution for injection 3ml pre-filled pens, Insulatard penfill 100 units/ml suspension for injection 3ml cartridges, Insulatard Innolet 100 units/ml suspension for injection 3ml pre-filled pens, Insulatard 100 units/ml suspension for injection 10ml vials, Metformin/vildagliptin 1000mg/50mg tablets, Metformin/vildagliptin 850mg/50mg tablets, Nepafenac 3mg/ml eye drops and Toremifine 60mg tablets.

  118. Added the following medicines: Epirubicin 200mg/100ml solution for infusion vials; Streptokinase 250,000 unit powder for solution for infusion vials; and Streptokinase 1.5 million unit powder for solution for infusion vials. Removed: Spectrila 10,000 units powder for solution for injection; Zirabev 100mg/4ml solution for infusion vials; Zykadia 150mg tablets; Xigduo 5mg/1000mg tablets; Xigduo 5mg/850mg tablets; Indivina 1mg/2.5mg tablets; Indivina 2mg/5mg tablets; Insuman Comb 50 100units/ml suspension for injection 3ml cartridges; Insulin isophane biphasic human 50/50 100units/ml suspension for injection 3ml cartridges; Ibrance 100mg tablets; Ibrance 125mg tablets; Ibrance 75mg tablets; Onpattro 2 mg/mL concentrate for solution for infusion; Somavert 20mg powder and solvent for solution for injection vials; Kisqali 200mg tablets; Ozempic 0.25mg/0.19ml solution for injection 1.5ml pre-filled pens; Ozempic 0.5mg/0.37ml solution for injection 1.5ml pre-filled pens; and Metalyse 10,000unit powder and solvent for solution for injection vials.

  119. Updated to remove 'Forxiga 10mg tablets' and 'Dapagliflozin 10mg tablets' from the list.

  120. Uploaded a corrected CSV attachment, adding: 'Topotecan 4mg/4ml concentrate for solution for infusion vials' and removing: 'Topotecan 4mg powder for solution for infusion vials'.

  121. Updated list of medicines. Removed: Topotecan 4mg/4ml concentrate for solution for infusion vials. Added: Spectrila 10,000 units powder for solution for injection; Asparginase 10,000 units powder for solution for injection; Xigduo 5mg/1000mg tablets; Dapagliflozin 5mg/Metformin 1g tablets; Xigduo 5mg/850mg tablets; Dapagliflozin 5mg/Metformin 850mg tablets; Forxiga 10mg tablets; Dapagliflozin 10mg tablets; Topotecan 4mg powder for solution for infusion vials.

  122. Updated the CSV file of medicines that can be moved through NIMAR. Adding: Cell-based quadrivalent influenza vaccine (surface antigen, inactivated) suspension for injection 0.5ml pre-filled syringes; NeoRecormon 20,000units/0.6ml solution for injection pre-filled syringes; Epoetin beta 20,000units/0.6ml solution for injection pre-filled syringes; Ozempic 0.25mg/0.19ml solution for injection 1.5ml pre-filled pens; Semaglutide 0.25mg/0.19ml solution for injection 1.5ml pre-filled disposable device. Removing: Flucelvax Tetra vaccine suspension for injection 0.5ml pre-filled syringes; Influenza vaccine (surface antigen, inactivated) suspension for injection 0.5ml pre-filled syringes.

  123. Added the following to the list of medicines that can be moved through NIMAR: Amlodipine/Valsartan 10mg/160mg, Amlodipine/Valsartan 5mg/160mg, Amlodipine/Valsartan 5mg/80gm, Fluorouracil 2.5g/100ml solution for infusion vials, Palbociclib 100mg tablets, Palbociclib 125mg tablets, Palbociclib 75mg tablets, Fluenz Tetra vaccine nasal suspension 0.2ml unit dose, Flucelvax Tetra vaccine suspension for injection 0.5ml pre-filled syringes, Ozempic 0.5mg/0.37ml solution for injection 1.5ml pre-filled pens, Imvanex vaccine suspension for injection 0.5ml vials, Metalyse 10,000unit powder and solvent for solution for injection vials, Topotecan 4mg powder for solution for infusion vials.

  124. Added the following to the list: Bevacizumab 100mg/4ml solution for infusion vials, Ceritinib 150mg tablets, Enbrel paediatric 10mg powder and solvent for injection vials, Estradiol valerate 1mg / Medroxyprogesterone 2.5mg tablets, Estradiol valerate 2mg / Medroxyprogesterone 5mg tablets, Etanercept 10mg powder and solvent for injection vials, Ibrance 75mg capsules, Ibrance 100mg capsules, Ibrance 125mg capsules, Indivina 1mg/2.5mg tablets, Indivina 2mg/5mg tablets, Kisqali 200mg tablets, Lapatinib 250mg tablets, Palbociclib 75mg capsules, Palbociclib 100mg capsules, Palbociclib 125 mg capsules, Pegvisomant 20mg powder and solvent for solution for injection vials, Ribociclib 200mg tablets , Somavert 20mg powder and solvent for solution for injection vials, Tyverb 250mg tablets (84 tablet), Zirabev 100mg/4ml solution for infusion vials and Zykadia 150mg tablets.

  125. Added to the list: Onpattro 2 mg/mL concentrate for solution for infusion; Patisiran 2 mg/mL concentrate for solution for infusion.

  126. Added Everolimus 3mg dispersible tablets sugar free, Nilotinib 150mg capsules, Pazopanib 200mg tablets, and Pazopanib 400mg tablets.

  127. Updated to remove Glucagon 0.5mg solution for injection in pre-filled pen from the list.

  128. Added Silver Sulfadiazine Cream 1%, Glucagon 0.5mg solution for injection in pre-filled pen, Glucagon 1mg solution for injection in pre-filled pen. Removed Estradiol 0.06% gel (750microgram per actuation).

  129. Replaced spreadsheet with updated version with the following listing: 'Fondaparinux sodium 7.5mg/0.6ml solution for injection, pre-filled syringe'.

  130. Added fondaparinux 5mg, 7mg and 10mg to the list of medicines that can be moved through NIMAR.

  131. Added bexarotene 75mg capsules to and removed eltrombopag 75mg capsules and thiopental from the list of medicines that can be moved through NIMAR.

  132. Replaced spreadsheet with updated version listing Buccolam as the brand name for Midazolam.

  133. Added Acetylcysteine, Canagliflozin, Eltrombopag, Estradiol, Insulin isophane, Midazolam, Progesterone and Topotecan to the list of medicines that can be moved through NIMAR.

  134. Added Etanercept 50mg/1ml, Somatropin (rbe) (5mg/1.5ml, 10mg/1.5ml, 15mg/1.5ml) and Thiopental 500mg powder to the list of medicines that can be moved through NIMAR.

  135. Added 'Cobimetinib 20mg tablets' to the list of medicines that can be moved through NIMAR.

  136. Added 2 new lines to the list: sodium chloride 0.18% + glucose 4% infusion bags and sucralfate 1g/5ml liquid.

  137. First published.

Sign up for emails or print this page